CHICAGO - U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc's Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries.
- Manufacturers' tests of procedures to clean medical scopes linked with "superbug" outbreaks contained flaws that render their cleaning instructions unreliable, according to a senior official with the U.S. Food and Drug Administration.
(Reuters Health) - Many parents ask doctors to spread out toddlers' vaccines instead of following the recommended immunization schedule, according to a new study.
- Lumber Liquidators Holdings Inc, a retailer of hardwood flooring in North America, sold flooring with higher levels of formaldehyde than permitted under California's health and safety standards, according to television news program "60 Minutes".
- The U.S. Food and Drug Administration rejected Pacira Pharmaceuticals Inc's application for expanding the use of its post-surgery pain drug, Exparel.
MACENTA, Guinea (Thomson Reuters Foundation) - In a land where witchcraft is sought after more than science for curing illness, medicine men in Guinea say the Ebola epidemic would be over by now if they had been properly included in the outbreak response.
- Amgen Inc's Kyprolis helped patients with relapsed multiple myeloma live twice as long before their blood cancer worsened compared to a regimen containing rival drug Velcade, according to an interim analysis announced by the company on Sunday.
SEOUL - North Korea is ending a ban on foreign tourists imposed more than four months ago because of worries about the spread of the deadly Ebola virus, two tour operators and a source in regular contact with North Korean officials said on Monday.
FREETOWN - Sierra Leone's Vice President Samuel Sam-Sumana said on Saturday that he had placed himself in a 21-day quarantine after one of his bodyguards died of Ebola amid a worrying recent surge in new infections in the West African nation.
BEIJING - China said on Saturday it would implement drug distribution reforms including centralization measures designed to cut prices and reduce corruption.